What are the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for Autism Spectrum Disorder (ASD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DSM-5 Criteria for Autism Spectrum Disorder

The DSM-5 consolidated previous pervasive developmental disorders into a single diagnosis of Autism Spectrum Disorder (ASD) with two core diagnostic domains: (1) persistent deficits in social communication and social interaction, and (2) restricted, repetitive patterns of behavior, interests, or activities. 1

Core Diagnostic Domains

Domain 1: Social Communication and Interaction Deficits

All of the following must be present (currently or by history):

  • Deficits in social-emotional reciprocity
  • Deficits in nonverbal communicative behaviors used for social interaction (such as eye contact, body language, gestures)
  • Deficits in developing, maintaining, and understanding relationships

Domain 2: Restricted, Repetitive Patterns of Behavior, Interests, or Activities

At least two of the following must be present (currently or by history):

  • Stereotyped or repetitive motor movements, use of objects, or speech
  • Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal behavior
  • Highly restricted, fixated interests that are abnormal in intensity or focus
  • Hyper- or hypo-reactivity to sensory input or unusual interest in sensory aspects of the environment

1, 2

Key Diagnostic Changes from DSM-IV-TR

The DSM-5 reduced diagnostic domains from three to two, eliminating the separate communication domain and incorporating it into social communication deficits. 1 This change reflects evidence showing little support for reliable diagnostic differences among the previous categories (autistic disorder, Asperger's disorder, PDD-NOS). 1

Critical Modifications:

  • Onset timing: Changed from "before 3 years of age" to "onset in the early developmental period" 1
  • Sensory features: Now explicitly incorporated as part of restricted/repetitive behaviors 1
  • Historical symptoms: Criteria allow for symptoms that may not be currently present but were documented historically, recognizing that intervention or development may reduce some symptoms over time 1
  • Severity specifiers: Added three levels (1-3) for each core domain indicating level of support needed 1

Additional Diagnostic Specifiers

The DSM-5 requires documentation of:

  • Presence or absence of intellectual impairment
  • Presence or absence of language impairment
  • Association with known medical, genetic, or environmental factors
  • Association with catatonia
  • Severity level for each core domain (Level 1: requiring support; Level 2: requiring substantial support; Level 3: requiring very substantial support)

1

Important Clinical Caveats

The severity levels show significant variability in clinical application, with less than half (40.4%) of children with documented ASD diagnoses having any severity level specified in their records. 3 Agreement between clinicians on severity ratings is only fair for social communication (κ = 0.318) and slight for restricted/repetitive behaviors (κ = 0.195), even when overall diagnostic agreement is high. 4 This suggests that assigning severity levels represents a distinct clinical decision beyond making the diagnosis itself.

The elimination of separate diagnoses (Asperger's, PDD-NOS) under the ASD umbrella was controversial but based on lack of evidence for reliable differentiation. 1 Clinicians should be aware that some individuals previously diagnosed under DSM-IV-TR criteria may not meet DSM-5 criteria, though the practical impact on prevalence remains under study.

Related Questions

What are alternative treatments to applied behavior analysis (ABA) therapy for individuals with autism spectrum disorder?
What comprehensive psychological evaluation should be performed for a 5-year-old child suspected of autism spectrum disorder?
What are the DSM‑5‑TR criteria for diagnosing Autism Spectrum Disorder (ASD) and the recommended evaluation and treatment?
What is the recommended treatment plan for a patient with autism spectrum disorder (ASD) who has shown significant improvements in communication, eye contact, and social engagement, but still exhibits aggressive behaviors and self-injurious behaviors?
What are the two core domains in the DSM‑5 required to diagnose autism spectrum disorder?
What does anterior‑lateral hypokinesis on a transthoracic echocardiogram indicate, and what are the recommended diagnostic and management steps?
Can I prescribe hydroxyzine for anxiety in a patient with a blood urea nitrogen of 25 mg/dL, normal creatinine and normal eGFR, and what dose and frequency are appropriate for severe anxiety?
Is emotional lability a side effect of glucagon‑like peptide‑1 (GLP‑1) receptor agonist therapy, and how should it be managed?
Are viral respiratory infections such as influenza being reported in pediatric emergency and outpatient clinics in Florida?
What is the recommended screening protocol for cardiac amyloidosis?
For a patient with severe generalized anxiety and normal renal function (BUN 25 mg/dL, normal creatinine and eGFR), is hydroxyzine or propranolol the better treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.